Dizal Pharmaceutical's Zegfrovy has taken the EGFR inhibitor class into new territory after hitting the mark in a phase 3 trial as a first-line treatment for non-small cell lung cancer (NSCLC) with ...
The once-daily oral drug improves patients’ lives while maintaining early, durable, and central nervous system responses, ...
Preclinical results in therapy-resistant HER2-low breast cancer models demonstrate enhanced antitumor activity and reversal of resistance with PLK1 inhibitionSAN DIEGO, March 19, 2026 (GLOBE NEWSWIRE) ...
Wall Street and healthcare stocks sank as Eli Lilly was downgraded, Novo’s Wegovy HD won FDA approval, and drug supply risks rose.
Estelamari Rodriguez, MD, MPH, is the associate director of community outreach for thoracic oncology and the assistant ...
A 20-year-old Canadian backpacker was raped in Byron Bay after she became lost on the beach at night and asked for directions ...
Detailed price information for Candel Therapeutics Inc (CADL-Q) from The Globe and Mail including charting and trades.
Doctors across the nation are alarmed that skepticism fueled by rising anti-science sentiment and medical mistrust is ...
Indian pharma companies prepare affordable semaglutide alternatives as demand for diabetes and weight-loss treatments grows ...
Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, ...
his dessert is a winner!
Some results have been hidden because they may be inaccessible to you
Show inaccessible results